Predicate |
Object |
contentType |
Clinical Trial|Journal Article|Multicenter Study|Randomized Controlled Trial |
endingPage |
95 |
issn |
0920-1211 |
issueIdentifier |
2-3 |
pageRange |
89-95 |
publicationName |
Epilepsy Research |
startingPage |
89 |
bibliographicCitation |
Grant R, Shorvon SD. Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy. Epilepsy Res. 2000 Dec;42(2-3):89–95. doi: 10.1016/s0920-1211(00)00158-3. PMID: 11074181. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f012908d886ca355add4ac81ef79a4de http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b3fbc40853976a98837112498385fb2 |
date |
200012 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/11074181 https://doi.org/10.1016/s0920-1211%2800%2900158-3 |
isPartOf |
https://portal.issn.org/resource/ISSN/0920-1211 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Efficacy and tolerability of 1000–4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy |
discusses |
http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0374035 http://id.nlm.nih.gov/mesh/M0016891 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D004827Q000188 http://id.nlm.nih.gov/mesh/D010889Q000031 http://id.nlm.nih.gov/mesh/D000927Q000008 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010889Q000008 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016037 http://id.nlm.nih.gov/mesh/D018709 http://id.nlm.nih.gov/mesh/D010865 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000077287 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6654 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6522 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284583 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6983 |